| scholarly article | Q13442814 |
| P2093 | author name string | Tong Zhou | |
| Ming Yao | |||
| Jin-Shui Zhu | |||
| Jin-Lian Chen | |||
| Ni-Wei Chen | |||
| Wei-Xiong Chen | |||
| Dong-Qing Zhang | |||
| Yun-Lin Wu | |||
| P2860 | cites work | Molecular studies into the role of CD44 variants in metastasis in gastric cancer | Q33706667 |
| The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer. | Q33763276 | ||
| The role of the E-cadherin/catenin complex in gastrointestinal cancer. | Q33848988 | ||
| Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated? | Q34083348 | ||
| Gastric adenocarcinoma: pathomorphology and molecular pathology | Q34226916 | ||
| Biologic therapy of inflammatory bowel disease. | Q34642879 | ||
| Soluble E-cadherin is a valid prognostic marker in gastric carcinoma | Q35363994 | ||
| Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody | Q35787976 | ||
| Relationship between phenotypes of cell-function differentiation and pathobiological behavior of gastric carcinomas. | Q36397335 | ||
| Clinicopathologic significance of sialyl Le(x) expression in advanced gastric carcinoma | Q36621614 | ||
| Differential expression of CD44v6 in metastases of intestinal and diffuse types of gastric carcinoma | Q37217754 | ||
| Establishment of a new scirrhous gastric cancer cell line with loss of heterozygosity at E-cadherin locus | Q40774216 | ||
| Characterization of a mutant E-cadherin protein encoded by a mutant gene frequently seen in diffuse-type human gastric carcinoma | Q40845028 | ||
| Tumor-derived mutated E-cadherin influences beta-catenin localization and increases susceptibility to actin cytoskeletal changes induced by pervanadate. | Q40877062 | ||
| Silencing of the CD44 gene by CpG methylation in a human gastric carcinoma cell line | Q40944698 | ||
| Hyaluronate binding assay study of transfected CD44 V4-V7 isoforms into the human gastric carcinoma cell line SC-M1. | Q41036522 | ||
| Abnormal expression and function of the E-cadherin-catenin complex in gastric carcinoma cell lines | Q42015210 | ||
| High CD99 expression in memory T and B cells in reactive lymph nodes | Q42678831 | ||
| A novel high throughput screening assay for HCV NS3 serine protease inhibitors | Q43041655 | ||
| Role of P-selectin and anti-P-selectin monoclonal antibody in apoptosis during hepatic/renal ischemia reperfusion injury | Q43073089 | ||
| Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. | Q50509931 | ||
| Immunohistochemical evaluation of cadherin and catenin expression in early gastric carcinomas: correlation with clinicopathologic characteristics and Helicobacter pylori infection. | Q53398115 | ||
| [Diffuse stomach carcinoma: from H&E diagnosis and molecular pathology to specific therapy] | Q53915934 | ||
| Rapid Detection of Mutated E-Cadherin in Peritoneal Lavage Specimens From Patients With Diffuse-Type Gastric Carcinoma | Q58197499 | ||
| E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma | Q59182686 | ||
| E-cadherin mutations in gastric carcinoma | Q59182720 | ||
| Up-regulated cytoplasmic expression, with reduced membranous distribution, of the src substrate p120(ctn) in gastric carcinoma | Q73147250 | ||
| Overexpression of laminin gamma2 chain monomer in invading gastric carcinoma cells | Q73163096 | ||
| E-cadherin mutation-based genetic counseling and hereditary diffuse gastric carcinoma | Q73263752 | ||
| Preferential overexpression of CD44v5 in advanced gastric carcinoma Goseki grades I and III | Q73330991 | ||
| E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas | Q73631136 | ||
| Molecular characterization of undifferentiated-type gastric carcinoma | Q73757919 | ||
| Loss of E-cadherin is the fundamental defect in diffuse-type gastric carcinoma and infiltrating lobular carcinoma of the breast | Q73855782 | ||
| CD44V6 in gastric carcinoma: a marker of tumor progression | Q73986234 | ||
| [Inhibition of human stomach cancer metastasis in vivo by anti-P-selectin monoclonal antibody] | Q74101864 | ||
| Remission of antiepiligrin (laminin-5) cicatricial pemphigoid after excision of gastric carcinoma | Q74120800 | ||
| Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma | Q74242722 | ||
| Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis | Q74484559 | ||
| Co-expression of N-cadherin and alpha-fetoprotein in stomach cancer | Q74531278 | ||
| Expression of CD44 containing variant exon 9 (CD44v9) in gastric adenomas and adenocarcinomas: relation to the proliferation and progression | Q74563009 | ||
| Genetic detection of lymph node micrometastases in patients with gastric carcinoma by multiple-marker reverse transcriptase-polymerase chain reaction assay | Q74610115 | ||
| [Clinical significance of molecular biological detection of micrometastases in gastric carcinoma] | Q77074808 | ||
| Association of E-cadherin germ-line alterations with prostate cancer | Q77161664 | ||
| Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma | Q77308619 | ||
| Expression of cell adhesion molecule CD44 and sialyl Lewis A in gastric carcinoma and colorectal carcinoma in association with hepatic metastasis | Q77410201 | ||
| Antiepiligrin (laminin 5) cicatricial pemphigoid associated with an underlying gastric carcinoma producing laminin 5 | Q77418228 | ||
| Molecular diagnostic detection of free cancer cells in the peritoneal cavity of patients with gastrointestinal and gynecologic malignancies | Q77839656 | ||
| Prognostic significance of CD44 and nm23 expression in patients with stage II and stage IIIA gastric carcinoma | Q77853317 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| immune function | Q124683452 | ||
| P304 | page(s) | 1607-1610 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Effect of P-selectin monoclonal antibody on metastasis of gastric cancer and immune function | |
| P478 | volume | 9 |
| Q90672492 | Antithrombotic Agents and Cancer |
| Q39103679 | C-type lectins facilitate tumor metastasis |
| Q33787907 | Effect of 2-(8-hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl) propionic acid in combination with carboplatin on gastric carcinoma growth in vivo |
| Q41900600 | Effect of non-anticoagulant N-desulfated heparin on basic fibroblast growth factor expression, angiogenesis, and metastasis of gastric carcinoma in vitro and in vivo |
| Q33269554 | Effect of non-anticoagulant N-desulfated heparin on expression of vascular endothelial growth factor, angiogenesis and metastasis of orthotopic implantation of human gastric carcinoma |
| Q91672059 | Endothelial cells in colorectal cancer |
| Q39770328 | EpCAM: a potential antimetastatic target for gastric cancer |
| Q42598619 | Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib |
| Q39062582 | Targeting P-selectin glycoprotein ligand-1/P-selectin interactions as a novel therapy for metabolic syndrome |
Search more.